IQVIA HOLDINGS INC. (IQV) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31..
Borrowing debt
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 1.84B USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 13.99B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 2.10B USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 29.68B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | (m) | $1.84B | $13.99B | (m) | $2.10B | $29.68B | (m) |
| 2025-12-31 | (m) | (m) | $1.84B | $13.88B | (m) | $2.14B | $29.94B | (m) |
| 2025-09-30 | (m) | (m) | $2.16B | $12.79B | (m) | $1.97B | $28.73B | (m) |
| 2025-06-30 | (m) | (m) | $1.31B | $14.18B | (m) | $2.19B | $28.63B | (m) |
| 2025-03-31 | (m) | (m) | $1.22B | $13.11B | (m) | $1.88B | $27.32B | (m) |
| 2024-12-31 | (m) | (m) | $1.15B | $12.84B | (m) | $1.84B | $26.90B | (m) |
| 2024-09-30 | (m) | (m) | $1.22B | $12.29B | (m) | $1.71B | $27.18B | (m) |
| 2024-06-30 | (m) | (m) | $1.17B | $12.09B | (m) | $1.68B | $26.40B | (m) |
| 2024-03-31 | (m) | (m) | $717.00M | $12.82B | (m) | $1.57B | $26.57B | (m) |
| 2023-12-31 | (m) | (m) | $718.00M | $12.96B | (m) | $1.50B | $26.68B | (m) |
| 2023-09-30 | (m) | (m) | $1.31B | $12.32B | (m) | $1.33B | $25.98B | (m) |
| 2023-06-30 | (m) | (m) | $1.34B | $12.43B | (m) | $1.49B | $26.04B | (m) |
| 2023-03-31 | (m) | (m) | $1.34B | $11.83B | (m) | $1.60B | $25.74B | (m) |
| 2022-12-31 | (m) | (m) | $152.00M | $12.60B | (m) | $1.31B | $25.34B | (m) |
| 2022-09-30 | (m) | (m) | $151.00M | $12.24B | (m) | $1.36B | $24.22B | (m) |
| 2022-06-30 | (m) | (m) | $152.00M | $12.62B | (m) | $1.52B | $24.41B | (m) |
| 2022-03-31 | (m) | (m) | $90.00M | $12.55B | (m) | $1.49B | $24.97B | (m) |
| 2021-12-31 | (m) | (m) | $91.00M | $12.03B | (m) | $1.48B | $24.69B | (m) |
| 2021-09-30 | (m) | (m) | $91.00M | $12.08B | (m) | $1.57B | $24.03B | (m) |
| 2021-06-30 | (m) | (m) | $147.00M | $12.14B | (m) | $1.91B | $23.94B | (m) |
| 2021-03-31 | (m) | (m) | $144.00M | $12.09B | (m) | $2.40B | $24.47B | (m) |
| 2020-12-31 | (m) | (m) | $149.00M | $12.38B | (m) | $1.90B | $24.56B | (m) |
| 2020-09-30 | (m) | (m) | $144.00M | $12.20B | (m) | $1.54B | $23.84B | (m) |
| 2020-06-30 | (m) | (m) | $142.00M | $11.96B | (m) | $1.18B | $23.18B | (m) |
| 2020-03-31 | (m) | (m) | $139.00M | $11.89B | (m) | $990.00M | $23.08B | (m) |
| 2019-12-31 | (m) | (m) | $100.00M | $11.54B | (m) | $899.00M | $23.25B | (m) |
| 2019-09-30 | (m) | (m) | $98.00M | $11.44B | (m) | $920.00M | $22.89B | (m) |
| 2019-06-30 | (m) | (m) | $100.00M | $11.30B | (m) | $994.00M | $23.07B | (m) |
| 2019-03-31 | (m) | (m) | $100.00M | $11.19B | (m) | $991.00M | $23.11B | (m) |
| 2018-12-31 | (m) | (m) | $100.00M | $10.91B | (m) | $938.00M | $22.55B | (m) |
| 2018-09-30 | (m) | (m) | $101.00M | $10.52B | (m) | (m) | $22.50B | (m) |
| 2018-06-30 | (m) | (m) | $101.00M | $10.63B | (m) | (m) | $22.63B | (m) |
| 2018-03-31 | (m) | (m) | $104.00M | $10.34B | (m) | (m) | $23.23B | (m) |
| 2017-12-31 | (m) | (m) | $103.00M | $10.12B | (m) | (m) | $22.74B | (m) |
| 2017-09-30 | (m) | (m) | $103.00M | $9.65B | (m) | (m) | $22.45B | (m) |
| 2017-06-30 | (m) | (m) | $94.00M | $8.86B | (m) | (m) | $21.78B | (m) |
| 2017-03-31 | (m) | (m) | $91.00M | $8.25B | (m) | (m) | $21.18B | (m) |
| 2016-12-31 | (m) | (m) | $92.00M | $7.11B | (m) | (m) | $21.21B | (m) |
| 2015-12-31 | (m) | (m) | $48.50M | $2.42B | (m) | (m) | $3.93B | (m) |
| 2015-09-30 | (m) | (m) | $48.50M | $2.43B | (m) | (m) | $4.03B | (m) |
| 2015-06-30 | (m) | (m) | $48.50M | $2.44B | (m) | (m) | $3.34B | (m) |
| 2014-12-31 | (m) | (m) | $750.00K | $2.29B | (m) | (m) | $3.31B | (m) |
| 2013-12-31 | (m) | (m) | $10.31M | $2.04B | (m) | (m) | $3.07B | (m) |
| 2012-12-31 | (m) | (m) | $55.59M | $2.37B | (m) | (m) | $2.50B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |